Fetal Rhesus typing
Approximately 17% of pregnant women in Germany are Rhesus D-negative. If the fetus is Rhesus D-positive the pregnant woman can develop antibodies against the fetus and there may be complications. Therefore, currently all Rhesus D-negative pregnant women get immunoglobulins as Rhesus prophylaxis.
Now, through the use of modern non-invasive molecular fetal diagnostics via real-time PCR typing, pregnant women can have their blood tested for the Rhesus D status of the unborn child. Since July 2021, this molecular genetic prenatal determination has also been included as a health insurance benefit in Germany.
With the new FastQ® RHD fetal kit, dedicated anti-D prophylaxis is possible. The kit reliably detects the Rhesus D status of the fetus: 3 exons of the RHD gene are examined by real-time PCR analysis. By detecting the three exons 5, 7 and 10, the probability of a false negative result is extremely minimized.
We offer the following kits for fetal Rhesus typing: